Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 47(4): 328-333, 8/4/2014. graf
Article Dans Anglais | LILACS | ID: lil-705768

Résumé

In cardiac and skeletal muscle, eugenol (μM range) blocks excitation-contraction coupling. In skeletal muscle, however, larger doses of eugenol (mM range) induce calcium release from the sarcoplasmic reticulum. The effects of eugenol are therefore dependent on its concentration. In this study, we evaluated the effects of eugenol on the contractility of isolated, quiescent atrial trabeculae from male Wistar rats (250-300 g; n=131) and measured atrial ATP content. Eugenol (1, 3, 5, 7, and 10 mM) increased resting tension in a dose-dependent manner. Ryanodine [100 µM; a specific ryanodine receptor (RyR) blocker] and procaine (30 mM; a nonspecific RyR blocker) did not block the increased resting tension induced by eugenol regardless of whether extracellular calcium was present. The myosin-specific inhibitor 2,3-butanedione monoxime (BDM), however, reversed the increase in resting tension induced by eugenol. In Triton-skinned atrial trabeculae, in which all membranes were solubilized, eugenol did not change resting tension, maximum force produced, or the force vs pCa relationship (pCa=-log [Ca2+]). Given that eugenol reduced ATP concentration, the increase in resting tension observed in this study may have resulted from cooperative activation of cardiac thin filaments by strongly attached cross-bridges (rigor state).


Sujets)
Animaux , Mâle , Calcium/physiologie , Eugénol/pharmacologie , Couplage excitation-contraction/effets des médicaments et des substances chimiques , Atrium du coeur/effets des médicaments et des substances chimiques , Force musculaire/effets des médicaments et des substances chimiques , Contraction myocardique/effets des médicaments et des substances chimiques , Adénosine triphosphate/analyse , Anesthésiques locaux/pharmacologie , Eugénol/administration et posologie , Techniques in vitro , Luciferases , Muscles squelettiques/effets des médicaments et des substances chimiques , Procaïne/pharmacologie , Rat Wistar , Ryanodine/pharmacologie
SÉLECTION CITATIONS
Détails de la recherche